Pharma

Brigham and Women’s starts hand transplants (Morning Read)

Brigham and Women’s Hospital, the Boston hospital that last year performed the nation’s first face transplant, now plans to offer hand transplants under an experimental program announced Monday, the Boston Globe reports.

Highlights of the important and interesting in the world of healthcare:

Hand transplant program. Brigham and Women’s Hospital, the Boston hospital that last year performed the nation’s first face transplant, now plans to offer hand transplants under an experimental program announced Monday, the Boston Globe reports.

Embryonic stem cell ruling shocks scientists. A federal district judge on Monday blocked President Obama’s 2009 executive order expanding embryonic stem cell research, saying it violated a ban on federal money being used to destroy embryos, according to the New York Times.

FDA researches nanotech. The Food and Drug Administration is hosting a workshop next month to get information on the safety and effectiveness of medical devices that use nanotechnology.

Hooray for Purell! Businesses that use alcohol-based hand disinfectants can reduce illness and absenteeism among workers, according to a report by German scientists.

Health equality. Screening and treating high-risk people for cardiovascular disease may be ineffective and widen social inequalities, according to a study by the Public Library of Science.

Cozy with big pharma. Consumers think doctors are too cozy with big pharma, according to the 2nd annual prescription drug survey conducted by Consumer Reports National Research Center.

Too many images? Over-using medical imaging services exposes patients to unnecessary radiation and adds to healthcare costs, according to a report appearing online and in the October issue of the journal Radiology that calls on radiologists to collaborate to curb over-utilization.